Ness Ziona

BiondVax Begins Phase IIa Study for Universal Flu Vaccine

Frost & Sullivan Awards "2010 European Influenza Vaccines Technology Innovation Award" to BiondVax Pharmaceuticals for Universal Influenza Vaccine

NESS ZIONA, Israel, October 11, 2010 - BiondVax Pharmaceuticals Ltd.

Older News

NESS ZIONA, Israel, July 28, 2010 - Frost & Sullivan is pleased to announce the award of its prestigious 2010 European Influenza Vaccines Technology Innovation Award (www.biondvax.com/image/users/128084/ftp/my_files/Documents/BiondVax%20-%20Technology%20Innovation.pdf?id=3635857)to BiondVax Pharmaceuticals ("BiondVax") (www.biondvax.com/) for their breakthrough work on a universal influenza vaccine.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy